|
Djuric, Zora; Vanloon, Glee; Radakovich, Katherine et al. (2008) Design of a Mediterranean exchange list diet implemented by telephone counseling. J Am Diet Assoc 108:2059-65
|
|
Corbett, Thomas H; White, Kathryn; Polin, Lisa et al. (2003) Discovery and preclinical antitumor efficacy evaluations of LY32262 and LY33169. Invest New Drugs 21:33-45
|
|
Polin, Lisa; White, Kathryn; Kushner, Juiwanna et al. (2002) Preclinical efficacy evaluations of XK-469: dose schedule, route and cross-resistance behavior in tumor bearing mice. Invest New Drugs 20:13-22
|
|
Poondru, Srinivasu; Parchment, Ralph E; Purohit, Vivek et al. (2002) Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30. Invest New Drugs 20:23-33
|
|
Poondru, S; Zhou, S; Rake, J et al. (2001) High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma. J Chromatogr B Biomed Sci Appl 759:175-8
|
|
LoRusso, P M; Foster, B J; Wozniak, A et al. (2000) Phase I pharmacokinetic study of the novel antitumor agent SR233377. Clin Cancer Res 6:3088-94
|
|
Keyes, K A; Albella, B; LoRusso, P M et al. (2000) Cytotoxic chemotherapy regimens that increase dose per cycle (dose intensity) by extending daily dosing from 5 consecutive days to 28 consecutive days and beyond. Clin Cancer Res 6:2474-81
|
|
Corbett, T H; Panchapor, C; Polin, L et al. (1999) Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin. Invest New Drugs 17:17-27
|
|
Edelstein, M; Corbett, T; Valeriote, F (1998) In vitro screening model for the detection of agents active against myelogenous leukemia. Cancer Invest 16:303-8
|
|
Perni, R B; Wentland, M P; Huang, J I et al. (1998) Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives. J Med Chem 41:3645-54
|
Showing the most recent 10 out of 33 publications
